Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Habib AG is a Swiss-based medical technology and biotechnology company founded by Professor Nagy Habib, a pioneer in liver surgery and oncology. The company focuses on the development and commercialization of innovative surgical tools and therapeutic approaches for the treatment of solid tumors, particularly in the liver and pancreas. Its flagship products include radiofrequency-based surgical devices designed to minimize blood loss and improve outcomes during complex resections. Beyond hardware, the entity is associated with the clinical development of novel therapies aimed at enhancing surgical precision and patient recovery in oncology settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr Habib A G.